secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neumora Therapeutics, Inc. (NMRA)
CIK:        0001885522
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001193125-26-009727
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neumora Therapeutics furnishes corporate presentation for J.P. Morgan conference; full content not disclosed in filing
--------------------------------------------------------------------------------

- Corporate presentation made available under Item 7.01, not filed for SEC purposes.
- Presentation used at 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026.
- No specific pipeline, financial, or operational updates can be extracted from the filing or incomplete exhibit.
- Exhibit 99.1 was not fully provided, limiting assessment of material new information.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1885522/000119312526009727/0001193125-26-009727-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1885522/000119312526009727/d34054d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-009727

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer